$Eyenovia(EYEN.US$ up and up only with good news on the way
They got a partnership 2 days ago
They got Vanguard support
Launch day near in August for eyedrop
Earning call in August
3rd FDA result is coming in October 2024
No dilution because Vanguard and partnership will support financially for eyen
After that, the revenue from 2 fda forecasts
Eyen financial free
what do you want?
They got a partnership 2 days ago
They got Vanguard support
Launch day near in August for eyedrop
Earning call in August
3rd FDA result is coming in October 2024
No dilution because Vanguard and partnership will support financially for eyen
After that, the revenue from 2 fda forecasts
Eyen financial free
what do you want?
2
$Eyenovia(EYEN.US$ Imagine after launch of eyedrop in August the revenue forecast 😳
1st + 2nd = 2FDA
Market Value:
1st FDA Market Value: 500M
2nd FDA Market Value: 1.3B
Just only capture 5 or 10 percent and 30 to 50 percent.
1,800,000,000×5% = $90,000,000 M per year
1,800,000,000×10%= $180,000,000 M per year
1,800,000,000×30% =540,000,000 M per year
1,800,000,000×50% =900,000,000 M per year
This only 2 FDA appro...
1st + 2nd = 2FDA
Market Value:
1st FDA Market Value: 500M
2nd FDA Market Value: 1.3B
Just only capture 5 or 10 percent and 30 to 50 percent.
1,800,000,000×5% = $90,000,000 M per year
1,800,000,000×10%= $180,000,000 M per year
1,800,000,000×30% =540,000,000 M per year
1,800,000,000×50% =900,000,000 M per year
This only 2 FDA appro...
+6
4
$Eyenovia (EYEN.US)$ Market Value are :
(Mydcombi)
1st FDA Market Value: 500M
(after surgery eyedrop for pain)
2nd FDA Market Value: 1.3B
(MicroPine)
3rd FDA Market Value: 1.8B
(Dry eyes)
4th FDA Market Value: 6B to 8B
................................
(Mydcombi)
1st FDA Market Value: 500M
(after surgery eyedrop for pain)
2nd FDA Market Value: 1.3B
(MicroPine)
3rd FDA Market Value: 1.8B
(Dry eyes)
4th FDA Market Value: 6B to 8B
................................
3
2
$Eyenovia(EYEN.US$ Eyen signed a partnership to make a new drug to treat the dry eyes and enter market value 6 to 8 billion.
3
$Eyenovia(EYEN.US$ Why MydCombi will be the king of cataract surgery for dilation?
These are the reasons:
1. Mydcombi will be used many times for dilation multiple patients, making it ideal for surgical settings.
2. Surgical institutions dispose of dilation medications after a single use/patient.
3. With approximately 7 million cataract surgeries performed annually in the United States. Mydcombi will help to save the potential a...
These are the reasons:
1. Mydcombi will be used many times for dilation multiple patients, making it ideal for surgical settings.
2. Surgical institutions dispose of dilation medications after a single use/patient.
3. With approximately 7 million cataract surgeries performed annually in the United States. Mydcombi will help to save the potential a...
+2
4
$Eyenovia(EYEN.US$ Imagine after launch of eyedrop the revenue forecast 😳
1st + 2nd = 2FDA
Market Value:
1st FDA Market Value: 500M
2nd FDA Market Value: 1.3B
Just only capture 5 or 10 percent.
1,800,000,000×5% = $90,000,000 M per year
1,800,000,000×10%= $180,000,000 M per year
This only 2 FDA approved
2 more FDA results coming in October or Q4 2024
and Market Value $6 B
1st + 2nd = 2FDA
Market Value:
1st FDA Market Value: 500M
2nd FDA Market Value: 1.3B
Just only capture 5 or 10 percent.
1,800,000,000×5% = $90,000,000 M per year
1,800,000,000×10%= $180,000,000 M per year
This only 2 FDA approved
2 more FDA results coming in October or Q4 2024
and Market Value $6 B
5
$Eyenovia (EYEN.US)$ They keep selling their first FDA MydCombi to Doctors office
That's why Vanguard and Insider keep buy multi million shares.
And second FDA new strongest eyedrop in the world sell starts in August
This is very good
That's why Vanguard and Insider keep buy multi million shares.
And second FDA new strongest eyedrop in the world sell starts in August
This is very good
3
$Eyenovia(EYEN.US$ For newbies, just search for "short trade." You will understand why one person always talks bad about this stock
After they short the stock
They are going to say ==> this company will be bankrupt soon, or they will say this company will do another stock offering dilution because they are shorting the stock.
Make you fear, and they make money.
They play with your emotions. Don't panic when stock goes down without no news and no reason because they are shorting.
They did ...
After they short the stock
They are going to say ==> this company will be bankrupt soon, or they will say this company will do another stock offering dilution because they are shorting the stock.
Make you fear, and they make money.
They play with your emotions. Don't panic when stock goes down without no news and no reason because they are shorting.
They did ...
5
1
$Eyenovia(EYEN.US$ First FDA helps eye doctor and surgeon to dilate eye like painting and very efficient.
The first FDA is selling in April.
The second FDA reduces time 50% and 99% pain relief and easy management for patients.
The second FDA is selling in August.
3 and 4 FDA results will be coming in Q4 2024.
CEO is talking about getting partnerships with another company to get funds more to study faster about dry eyes.
The first FDA is selling in April.
The second FDA reduces time 50% and 99% pain relief and easy management for patients.
The second FDA is selling in August.
3 and 4 FDA results will be coming in Q4 2024.
CEO is talking about getting partnerships with another company to get funds more to study faster about dry eyes.
+3
3
$Eyenovia(EYEN.US$ First FDA helps eye doctor and surgeon to dilate eye like painting and very efficient.
The first FDA is selling in April.
The second FDA reduces time 50% and 99% pain relief and easy management for patients.
The second FDA is selling in August.
3 and 4 FDA results will be coming in Q4 2024.
CEO is talking about getting partnerships with another company to get funds more to study faster about dry eyes.
The first FDA is selling in April.
The second FDA reduces time 50% and 99% pain relief and easy management for patients.
The second FDA is selling in August.
3 and 4 FDA results will be coming in Q4 2024.
CEO is talking about getting partnerships with another company to get funds more to study faster about dry eyes.
6